Explain this page
Arphra AIPlain-English read on Corcept Therapeutics Incorporated’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for CORT.
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.27% | +7.70% | +35.51% | +95.18% | -12.66% | +100.23% | -2.79% | +203.35% | +223.49% | +1057.48% | +469.75% |
Aftermarket
LiveLast trade
$69.68
1 sh
Bid
$63.85
2 sh
Ask
$74.29
2 sh
Spread
$10.440
Sector & industry today
LiveSectors
- Technology+2.44%
- Energy+1.31%
- Consumer Cyclical+0.18%
- Real Estate-0.27%
- Industrials-0.28%
- Financial Services-0.30%
- Consumer Defensive-0.46%
- Healthcare-0.70%
- Basic Materials-1.03%
- Utilities-1.10%
- Communication Services-1.25%
Top industries (issuer's industry highlighted)
- Biotechnology-1.45%
- Integrated Freight & Logistics-12.58%
- Information Technology Services+8.89%
- Computer Hardware+5.74%
- Coal+4.42%
- Software - Application+2.70%
- Electronic Gaming & Multimedia-2.49%
- Luxury Goods-1.97%
- Industrial - Pollution & Treatment Controls-1.89%
- Gambling, Resorts & Casinos+1.88%
- Communication Equipment+1.80%
- Agricultural Inputs-1.65%
Fair value
Football field →Weighted blend
$17.07
-75.50% vs spot
Recommendation
Sell
4 of 4 methods
Method spread
0bull4bear
±5% threshold
Analyst PT consensus: $79.67 (+14.34%)
Total assets
$836.65M
Total debt
$6.11M
Cash & equiv
$120.5M
Operating CF
$142M
Free cash flow
$141.79M
Buybacks
-$245.86M
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $164.9M | -$31.2M | $-0.30 |
| Q4 Dec 2025 | $202.13M | $24.29M | $0.20 |
| Q3 Sep 2025 | $207.64M | $19.67M | $0.16 |
| Q2 Jun 2025 | $194.43M | $35.15M | $0.29 |
| Q1 Mar 2025 | $157.21M | $20.55M | $0.17 |
| Q4 Dec 2024 | $181.89M | $30.39M | $0.26 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $761.41M | $44.8M | $99.65M | $0.82 | +13.09% |
| FY 2024 | $675.04M | $136.95M | $139.73M | $1.23 | +20.70% |
| FY 2023 | $482.38M | $107.28M | $106.14M | $0.94 | +22.00% |
| FY 2022 | $401.86M | $112.63M | $101.42M | $0.87 | +25.24% |
| FY 2021 | $365.98M | $124.48M | $112.51M | $0.89 | +30.74% |